- Home
- DOO vs SRRK Comparison
DOO vs SRRK Comparison
Compare DOO & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$78.40
HOLD
Current Price
$43.90
Company Overview
Basic Information| Metric | DOO | SRRK |
|---|---|---|
| Founded | 1937 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | DOO | SRRK |
|---|---|---|
| Price | $78.40 | $43.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $75.00 | $51.20 |
| AVG Volume (30 Days) | 123.3K | ★ 1.0M |
| Earning Date | 12-04-2025 | 02-26-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $5,730,422,869.00 | N/A |
| Revenue This Year | $7.14 | N/A |
| Revenue Next Year | $6.01 | $20,029.43 |
| P/E Ratio | $342.57 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $31.78 | $22.71 |
| 52 Week High | $81.89 | $48.28 |
Technical Indicators
Market Signals| Indicator | DOO | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 53.14 | 49.68 |
| Support Level | $75.00 | $43.56 |
| Resistance Level | $81.89 | $48.28 |
| Average True Range (ATR) | 2.61 | 2.53 |
| MACD | 0.70 | -0.11 |
| Stochastic Oscillator | 67.92 | 43.83 |
Price Performance
Historical Comparison DOO
SRRK
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.